A systematic review of interventions by healthcare professionals on community-dwelling postmenopausal women with osteoporosis

Lai, Pauline Siew Mei; Chua, SS; Sp, Chan

doi:10.1007/s00198-010-1199-0

Cited by 14 publications

(17 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We also note that none of the studies examined the impact of the pharmacist interventions on osteoporosis treatment adherence or considered pharmacists’ experience or satisfaction with the osteoporosis management programs. Recent reviews of the literature identify that strategies that enhance patient and healthcare provider communication and treatment follow-up may be key to improving adherence to osteoporosis pharmacotherapy [5, 47, 48]. Further study is thus important to identify the impact of pharmacy interventions on treatment initiation and adherence to therapy, as well as to examine the feasibility of osteoporosis management in community pharmacy.…”

Section: Discussionmentioning

confidence: 99%

“…Further study is thus important to identify the impact of pharmacy interventions on treatment initiation and adherence to therapy, as well as to examine the feasibility of osteoporosis management in community pharmacy. Interventions in osteoporosis management by physicians, physiotherapists, nurses, dieticians, and other healthcare professionals working in teams have helped to improve treatment adherence and calcium intake among community-dwelling women [5] and increase BMD testing and osteoporosis treatment rates in patients post-fracture [4]. …”

Section: Discussionmentioning

confidence: 99%

“…Second, pharmacists can provide counseling and educate patients on medication use, fall prevention, and the importance of calcium, vitamin D, exercise, and adherence to therapy. A recent review identified that non-drug interventions by healthcare professionals improved quality of life, treatment adherence, and calcium intake among community-dwelling postmenopausal women with osteoporosis; however, no study within the review examined pharmacist interventions [5]. We therefore completed a systematic review of the literature to identify all articles that have examined the impact of pharmacist interventions in osteoporosis management.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The impact of pharmacist interventions on osteoporosis management: a systematic review

2011

View full text Add to dashboard Cite

SummaryWe completed a systematic review of the literature to examine the impact of pharmacist interventions in improving osteoporosis management. Results from randomized controlled trials suggest that pharmacist interventions may improve bone mineral density testing and calcium intake among patients at high risk for osteoporosis.IntroductionPharmacists play a key role in many healthcare systems by helping patients manage chronic diseases. We completed a systematic review of the literature to identify randomized controlled trials (RCTs) that have examined the impact of pharmacy interventions in narrowing two gaps in osteoporosis management: identifying at-risk individuals and improving adherence to therapy.MethodsWe searched the electronic databases of EMBASE, HealthStar, International Pharmaceutical Abstracts, MEDLINE, and PubMed from database development to April 2010, examined grey literature, and completed manual searches of reference lists to identify English-language research that examined osteoporosis management interventions within pharmacy practice. Results from RCTs were abstracted and assessed for bias.ResultsWe identified 25 studies that examined pharmacist interventions in osteoporosis management: 16 cohort, 5 cross-sectional, 1 historical/ecological control, and 3 RCTs. RCT interventions included osteoporosis educational and counseling programs, screening by pharmacists based on risk factor assessment or bone mineral density testing, and physician contact or recommendations for patients to follow-up with a general practitioner. Results from the three RCTs suggest that pharmacist interventions may improve bone mineral density testing (targeted screening) and calcium intake among patients at high risk for osteoporosis. However, two of the three RCTs had high risk of bias, and no study examined the impact of pharmacist intervention on osteoporosis treatment adherence.ConclusionsData support the potential role for pharmacists to help reduce gaps in osteoporosis management through improved identification of high-risk patients. More research is needed to examine pharmacist interventions on osteoporosis treatment adherence.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The impact of pharmacist interventions on osteoporosis management: a systematic review

2011

View full text Add to dashboard Cite

show abstract

“…Healthcare professionals should receive adequate osteoporosis education in their academic programs in order to give them adequate knowledge of the disease to prepare them for treating this population. A systematic review of interventions by healthcare professionals on community-dwelling postmenopausal women with osteoporosis defined these interventions by consultation with physicians, nurses, pharmacists, physical therapists, and dietitians [8]. Physicians who treat individuals with osteoporosis have additional training after medical school with residencies and possible fellowships to prepare them to treat patients with the disease; therefore, this study investigated osteoporosis knowledge in students who were soon to be nurses, pharmacists, physical therapists, and dietitians.…”

Section: Introductionmentioning

confidence: 99%

Osteoporosis Knowledge of Students in Relevant Healthcare Academic Programs

Nguyen

Wang²

2012

Journal of Osteoporosis

View full text Add to dashboard Cite

For healthcare professionals who treat individuals with osteoporosis, it is vital that they receive adequate education on osteoporosis to ensure sufficient knowledge of osteoporosis to properly treat individuals with the disease. To test for adequate osteoporosis education, a study was conducted to measure osteoporosis knowledge in 206 students in relevant healthcare academic programs, such as nursing, pharmacy, physical therapy, and dietetics. The study showed that differences existed in osteoporosis knowledge in general between the programs and between different years of students in the same programs. There were also discrepancies in specific areas of osteoporosis knowledge between the classes of students, and the average scores of correctly answered items were only as high as 24.40 (76.3%) out of 32 items on osteoporosis knowledge. This study shows that students have osteoporosis knowledge and that it is not completely inadequate; however, osteoporosis knowledge could still be more sufficient, and results demonstrate the need to increase osteoporosis education in the curriculum for these healthcare academic programs to increase osteoporosis knowledge and better prepare graduates and professionals to treat individuals with the disease.

show abstract

“…Second, pharmacists can provide counseling and educate patients on medication use, fall prevention, and the importance of calcium, vitamin D, exercise, and adherence to therapy. A recent review identified that non-drug interventions by healthcare professionals improved quality of life, treatment adherence, and calcium intake among community-dwelling postmenopausal women with osteoporosis 7 . Hence, this study aims to establish the relationship between the bone health and AED use the impact of pharmacist's intervention as well in improving the bone health, particularly in women epileptic patients taking AEDs.…”

Section: Introductionmentioning

confidence: 99%

Impact of Pharmaceutical Care on Bone Health in Epileptic Women Taking Antiepileptic Drugs: An Interventional Trial

Sabna¹,

Thomas²

2018

Int Res J Pharm

View full text Add to dashboard Cite

Antiepileptic drugs (AEDs) have adverse effects on bone mineral density (BMD) and an inverse relationship exists between bone health and the use of anti-epileptic drugs. The quality of bone is affected by the duration and the type of anti-epileptics used. Adults, particularly women are at more risk. The aim of the trial was to determine the impact of pharmaceutical care on bone mineral density of epileptic women taking AEDs for at least two years. Participants (n = 29) were randomly assigned to either control group or intervention group. The control group patients received usual physician care while the intervention group received interventions from a clinical pharmacist like educational intervention and pharmacotherapy intervention in the form of supplements. Primary outcome measures were femoral neck and lumbar spine BMD, which is expressed as T-score. BMD was determined by dual-energy X-ray absorptiometry (DEXA) in 30 epileptic women taking AEDs for more than two years. Outcomes were assessed at baseline and 12 months in both groups. The mean (±SD) changes in BMD in the intervention and control groups were: femoral neck +0.52±4.81 and-0.71±5.03 respectively (p<0.01) and spine +2.15±4.01 and +1.22±4.23 respectively (p<0.01). The difference between the interventional and control groups was significant at femoral neck and lumbar spine regions. We found that supplementation with calcium and vitamin D moderately reduced bone loss measured in femoral neck and lumbar spine regions over a one-year period through pharmacist-led intervention. Overall, the current study underscores the importance of pharmacist's intervention on bone health in epileptic women.

show abstract

A systematic review of interventions by healthcare professionals on community-dwelling postmenopausal women with osteoporosis

Cited by 14 publications

References 45 publications

The impact of pharmacist interventions on osteoporosis management: a systematic review

The impact of pharmacist interventions on osteoporosis management: a systematic review

Osteoporosis Knowledge of Students in Relevant Healthcare Academic Programs

Impact of Pharmaceutical Care on Bone Health in Epileptic Women Taking Antiepileptic Drugs: An Interventional Trial

Contact Info

Product

Resources

About